APOE and metabolic dysfunction-associated steatohepatitis: These studies include research based on atherosclerosis in apolipoprotein E‐knockout mice treated for 6 months,37 chronic allograft nephropathy in rats treated for 5 months 38 and non‐alcoholic steatohepatitis in mice treated for 8‐16 weeks.25, 26